Your browser doesn't support javascript.
loading
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Jain, Tania; Bar, Merav; Kansagra, Ankit J; Chong, Elise A; Hashmi, Shahrukh K; Neelapu, Sattva S; Byrne, Michael; Jacoby, Elad; Lazaryan, Aleksandr; Jacobson, Caron A; Ansell, Stephen M; Awan, Farrukh T; Burns, Linda; Bachanova, Veronika; Bollard, Catherine M; Carpenter, Paul A; DiPersio, John F; Hamadani, Mehdi; Heslop, Helen E; Hill, Joshua A; Komanduri, Krishna V; Kovitz, Craig A; Lazarus, Hillard M; Serrette, Justin M; Mohty, Mohamad; Miklos, David; Nagler, Arnon; Pavletic, Steven Z; Savani, Bipin N; Schuster, Stephen J; Kharfan-Dabaja, Mohamed A; Perales, Miguel-Angel; Lin, Yi.
Afiliación
  • Jain T; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Hematologic Malignancies and Bone Marrow Transplantation Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Bar M; Division of Clinical Research, Fred Hutchinson Cancer Research Center and Department of Medicine, University of Washington, Seattle, Washington.
  • Kansagra AJ; Department of Hematology and Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Chong EA; Lymphoma Program, Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania.
  • Hashmi SK; Division of Hematology, Mayo Clinic, Rochester, Minnesota; Oncology Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
  • Neelapu SS; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Byrne M; Division of Hematology and Medical Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Jacoby E; The Chaim Sheba Medical Center, Tel-Hashomer, Affiliated with the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Lazaryan A; Blood and Marrow Transplant and Cellular Immunotherapy Program, Moffitt Cancer Center, Tampa, Florida.
  • Jacobson CA; Immune Effector Cell Therapy Program, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Ansell SM; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Awan FT; Department of Hematology and Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Burns L; National Marrow Donor Program and Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota.
  • Bachanova V; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota.
  • Bollard CM; Center for Cancer and Immunology Research, Children's National Health System, Washington, DC.
  • Carpenter PA; Division of Clinical Research, Fred Hutchinson Cancer Research Center and Department of Medicine, University of Washington, Seattle, Washington; Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington.
  • DiPersio JF; Division of Oncology, Washington University School of Medicine, St Louis, Missouri.
  • Hamadani M; Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Heslop HE; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.
  • Hill JA; Division of Clinical Research, Fred Hutchinson Cancer Research Center and Department of Medicine, University of Washington, Seattle, Washington; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Komanduri KV; Division of Transplantation and Cellular Therapy, Sylvester Comprehensive Cancer Center, Miami, Florida.
  • Kovitz CA; Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lazarus HM; Division of Hematology and Oncology, Case Western Reserve University, Cleveland, Ohio.
  • Serrette JM; Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas.
  • Mohty M; Hematology and Cellular Therapy Department, Saint-Antoine Hospital, AP-HP, Sorbonne University, INSERM UMRs 938, Paris, France.
  • Miklos D; Division of Blood and Marrow Transplantation, Stanford University, Stanford, California.
  • Nagler A; Division of Hematology and Medical Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Pavletic SZ; Graft-versus-Host and Late Effects Section, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland.
  • Savani BN; Division of Hematology and Medical Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Schuster SJ; Lymphoma Program, Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania.
  • Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida. Electronic address: Mohamed@mayo.edu.
  • Perales MA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York. Electronic address: peralesm@mskcc.org.
  • Lin Y; Division of Hematology, Mayo Clinic, Rochester, Minnesota. Electronic address: Lin.Yi@mayo.edu.
Biol Blood Marrow Transplant ; 25(12): 2305-2321, 2019 12.
Article en En | MEDLINE | ID: mdl-31446199
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células B / Traslado Adoptivo / Receptores Quiméricos de Antígenos Tipo de estudio: Guideline País/Región como asunto: America do norte Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células B / Traslado Adoptivo / Receptores Quiméricos de Antígenos Tipo de estudio: Guideline País/Región como asunto: America do norte Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article